Modification of cysteinyl leukotriene receptors expression in capsular contracture: Follow-up study and definitive results

Annals of Plastic Surgery

Volumn 63, Issue 2, 2009, Pages 206-208

  Grella, Elisa ^a   Grella, Roberto ^a   Siniscalco, Dario ^a   Fuccio, Carlo ^a   Rossi, Francesco ^a   De Novellis, Vito ^a   Maione, Sabatino ^a   D'Andrea, Franceso ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Breast implant; Capsular contracture; CysLTR; Cysteinyl leukotriene receptors; Myofibroblast; Periprosthetic capsule

Indexed keywords

LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MESSENGER RNA; PEPTIDOLEUKOTRIENE; PROTEIN RECEPTOR CYSTEINYL LEUKOTRIENE RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; JOINT CONTRACTURE; MACROPHAGE ACTIVATION; MYOFIBROBLAST; PERIPROSTHETIC CAPSULAR CONTRACTURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN MODIFICATION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

ADULT; ANALYSIS OF VARIANCE; BLOTTING, WESTERN; BREAST IMPLANTS; CASE-CONTROL STUDIES; CONTRACTURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECEPTORS, LEUKOTRIENE;

EID: 68249142944     PISSN: 01487043     EISSN: None     Source Type: Journal    
DOI: 10.1097/SAP.0b013e31818937bc     Document Type: Article

References (32)

1. Lossing C, Hansson HA. Peptide growth factors and myofibroblasts in capsules around human breast implants. Plast Reconstr Surg. 1993;91: 1277-1286. (Pubitemid 23164632)
2. Rubino C, Mazzarello V, Farace F, et al. Ultrastructural anatomy of contracted capsules around textured implants in augmented breasts. Ann Plast Surg. 2001;46:95-102. (Pubitemid 32147316)
3. Prantl L, Schreml S, Fichtner-Feigl S, et al. Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg. 2007;120:275-284. (Pubitemid 46956064)
4. Prantl L, Angele P, Schreml S, et al. Determination of serum fibrosis indexes in patients with capsular contracture after augmentation with smooth silicone gel implants. Plast Reconstr Surg. 2006;118:224-229. (Pubitemid 44324193)
5. Prantl L, Poppl N, Horvat N, et al. Serologic and histologic findings in patients with capsular contracture after breast augmentation with smooth silicone gel implants: is serum hyaluronan a potential predictor? Aesthetic Plast Surg. 2005;29:510-518. (Pubitemid 43029784)
6. Poeppl N, Schreml S, Lichtenegger F, et al. Does the surface structure of implants have an impact on the formation of a capsular contracture? Aesthetic Plast Surg. 2007;31:133-139.
7. Schreml S, Heine N, Eisenmann-Klein M, et al. Bacterial colonization is of major relevance for high-grade capsular contracture after augmentation mammaplasty. Ann Plast Surg. 2007;59:126-130. (Pubitemid 47220413)
8. Henriksen TF, Fryzek JP, Holmich LR, et al. Surgical intervention and capsular contracture after breast augmentation: a prospective study of risk factors. Ann Plast Surg. 2005;54:343-351.
9. Macadam SA, Clugston PA, Germann ET. Retrospective case review of capsular contracture after 2-stage breast reconstruction: is colonization of the tissue expander pocket associated with subsequent implant capsular contracture? Ann Plast Surg. 2004;53:420-424.
10. Embrey M, Adams EE, Cunningham B, et al. A review of the literature on the etiology of capsular contracture and a pilot study to determine the outcome of capsular contracture interventions. Aesthetic Plast Surg. 1999;23:197-206. (Pubitemid 29284172)
11. Asakura T, Ishii Y, Chibana K, et al. Leukotriene D4 stimulates collagen production from myofibroblasts transformed by TGF-beta. J Allergy Clin Immunol. 2004;114:310-315. (Pubitemid 39119029)
12. Kanaoka Y, Boyce JA. Cysteinyl leukotrienes and their receptors: cellular distribution and function in immune and inflammatory responses. J Immunol. 2004;173:1503-1510. (Pubitemid 38971578)
13. Fabre JE, Goulet JL, Riche E, et al. Transcellular biosynthesis contributes to the production of leukotrienes during inflammatory responses in vivo. J Clin Invest. 2002;109:1373-1380. (Pubitemid 34546902)
14. Scuderi N, Mazzocchi M, Rubino C. Effects of zafirlukast on capsular contracture: controlled study measuring the mammary compliance. Int J Immunopathol Pharmacol. 2007;20:577-585. (Pubitemid 47531060)
15. Schlesinger SL, Ellenbogen R, Desvigne MN, et al. Zafirlukast (Accolate): a new treatment for capsular contracture. J Aesthetic Surg. 2002;22:329.
16. D'Andrea F, Nicoletti GF, Grella E, et al. Modification of cysteinyl leukotriene receptor expression in capsular contracture: preliminary results. Ann Plast Surg. 2007;58:212-214. (Pubitemid 46148635)
17. Bradford MM. A rapid and sensitive method for the quantization of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
18. Lee TH, Austen KF, Corey EJ, et al. Leukotriene E4-induced airway hyperresponsiveness of guinea pig smooth muscle to histamine and evidence for three separate sulfidopeptide leukotriene receptors. Proc Natl Acad Sci USA. 1984;81:4922.
19. Labat C, Ortiz JL, Norel X, et al. A second Cysteinyl leukotriene receptor in human lung. J Pharm Exp Ther. 1992;263:800.
20. Martin V, Sawyer N, Stocco R, et al. Molecular cloning and functional characterization of murine cysteinyl leukotriene 1 (CysLT) receptor. Biochem Pharmacol. 2001;63:1193. (Pubitemid 33055623)
21. Maekawa A, Kanoka Y, Lam BK, et al. Identification in mice of two isoforms of the cysteinyl leukotriene 1 receptor that result from alternative splicing. Proc Natl Acad Sci USA. 2001;98:2256. (Pubitemid 32209469)
22. Hui Y, Yang G, Galczenski H, et al. The murine cysteinyl leukotriene 2 (CysLT2) receptor: cDNA and genomic cloning, alternative splicing and in vitro characterization. J Biol Chem. 2001;276:47489. (Pubitemid 37373132)
23. Lynch KR, O'Neill GP, Liu Q, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature. 1999;399:789. (Pubitemid 29293175)
24. Sarau HM, Ames RS, Chambers J, et al. Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor. Mol Pharmacol. 1999;56:657. (Pubitemid 29406893)
25. Heise CE, O'Dowd BF, Figueroa DJ, et al. Characterization of the human cysteinyl leukotriene 2 receptor. J Biol Chem. 2000;275:30531-30536. (Pubitemid 30751375)
26. Ogasawara H, Ishii S, Yokomizo T, et al. Characterization of mouse cysteinyl leukotriene receptors mCysLT1 and mCysLT2: differential pharmacological properties and tissue distribution. J Biol Chem. 2002;277:18763-18768. (Pubitemid 34952434)
27. Takasaki J, Kamohara M, Matsumoto M, et al. The molecular characterization and tissue distribution of the human cysteinyl leukotriene CysLT2 receptor. Biophys Res Commun. 2000;274:316. (Pubitemid 30614317)
28. Thivierge M, Stankova J, Rola-Pleszczynski M. IL-13 and IL-4 up-regulate cysteinyl leukotriene 1 receptor expression in human monocytes and macrophages. J Immunol. 2001;167:2855-2860. (Pubitemid 32768919)
29. Accomazzo MR, Rovati GE, Vigano T, et al. Leukotriene D4-induced activation of smooth cells from human bronchi is partly Ca2+-indipendent. Am J Respir Crit Care Med. 2001;163:266.
30. Nagase TN, Uozumi N, Ishii S, et al. A pivotal role of cytosolic phospholipase A2 in bleomicin-induced pulmonary fibrosis. Nat Med. 2002;8:480. (Pubitemid 34546750)
31. Peters-Golden M, Bailie M, Marshall T, et al. Protection for pulmonary fibrosis in leukotriene deficient mice. Am J Respir Crit Care Med. 2002; 165:229. (Pubitemid 34084463)
32. Beller TC, Friend DS, Maekawa A, et al. Cysteinyl leukotriene 1 receptor controls the severity of chronic pulmonary inflammation and fibrosis. Proc Natl Acad Sci USA. 2004;101:3047. (Pubitemid 38327732)